Steve Miller - Dec 13, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Stock symbol
CPRX
Transactions as of
Dec 13, 2024
Transactions value $
$942,350
Form type
4
Date filed
12/17/2024, 05:24 PM
Previous filing
Dec 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $942K +235K +34.21% $4.01 922K Dec 13, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -235K -13.15% $0.00 1.55M Dec 13, 2024 Common Stock 235K $4.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vested in three annual tranches beginning on January 2, 2019.